Yaniv Zohar

2.0k citations
62 papers · 1.3k indexed · h-index 20
Topics
T-cell and B-cell Immunology (10 papers)Proteoglycans and glycosaminoglycans research (8 papers)Immune Cell Function and Interaction (6 papers)

In The Last Decade

Yaniv Zohar

56 papers receiving 1.2k citations

Peers

Yaniv Zohar
Comparison fields: 5 of 92
  • Immunology 518
  • Oncology 472
  • Molecular Biology 346
  • Pulmonary and Respiratory Medicine 176
  • Cell Biology 159
Replace Kazushige Sakaguchi with:
Kazushige Sakaguchi Japan
Kota Iwahori Japan
Alexander Rosendahl Sweden
Zoltán Jakus Hungary
Seong Hoe Park South Korea
Maciej Bogdan Maniecki Denmark
Jörn Gröne Germany
Yongzhong Liu China
Minghua Zhu United States
Carmen Marchiol France
Yaniv Zohar relative to Kazushige Sakaguchi Japan Kazushige Sakaguchi's profile →
Citations per field
00.5×4.2×
Kazushige Sakaguchi · 1×
Citations per year

Countries citing papers authored by Yaniv Zohar

Since Specialization
Citations

This map shows the geographic impact of Yaniv Zohar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaniv Zohar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaniv Zohar more than expected).

Fields of papers citing papers by Yaniv Zohar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaniv Zohar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaniv Zohar. The network helps show where Yaniv Zohar may publish in the future.

Co-authorship network of co-authors of Yaniv Zohar

This figure shows the co-authorship network connecting the top 25 collaborators of Yaniv Zohar. A scholar is included among the top collaborators of Yaniv Zohar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaniv Zohar. Yaniv Zohar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 1
3 0
4 4
5 0
6 1
7 0
8 19
9 16
10 8
11 13
12 25
13 84
14 16
15 15
16 24
17 144
18 19
19 80
20 62

About Yaniv Zohar

Yaniv Zohar is a scholar working on Immunology, Oncology and Cell Biology, having authored 62 papers that have together received 1.3k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (10 papers), Proteoglycans and glycosaminoglycans research (8 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Immunology (518 citations), Oncology (472 citations) and Cell Biology (159 citations). Yaniv Zohar has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Gizi Wildbaum, Nathan Karin, Rachel Anunu, Gila Maor, Rostislav Novak, Yiftah Barsheshet, Israël Vlodavsky, Neta Ilan, Uri Barash and Andrew L. Salzman. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026